Cargando…

Honey as an immunomodulator during sepsis in animal model

Detalles Bibliográficos
Autores principales:	Kassim, M, Mansor, M, Achoui, M, Yan, OS, Devi, S, Yusoff, KM
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776213/ http://dx.doi.org/10.1186/cc8096

Ejemplares similares

Gelam Honey Scavenges Peroxynitrite During the Immune Response
por: Kassim, Mustafa, et al.
Publicado: (2012)

The importance of antibiotics in animal models of sepsis
por: Maybauer, MO, et al.
Publicado: (2005)

Clinical severity and local inflammatory responses in animal models of sepsis
por: Saeed, S, et al.
Publicado: (2010)

Atorvastatin and simvastatin protects cognitive impairment in an animal model of sepsis
por: Alexandre, Pedro CB, et al.
Publicado: (2013)

0729. Interstitial changes in spleen during sepsis
por: Svendsen, ØS, et al.
Publicado: (2014)

Gelam Honey Has a Protective Effect against Lipopolysaccharide (LPS)-Induced Organ Failure
por: Kassim, Mustafa, et al.
Publicado: (2012)

Arginine metabolism in a small animal model of sepsis and after hemihepatectomy
por: Hoven, B Van der, et al.
Publicado: (2009)

Test characteristics of acute kidney injury biomarkers in animal models of sepsis
por: Peng, Z, et al.
Publicado: (2014)

Changes in MIF and thyroxine, in a clinically relevant large animal model of sepsis
por: Miller, E, et al.
Publicado: (2009)

Modeling sepsis using neural nets and biomarkers of organ dysfunction in patients, with links to animal models
por: Schentag, J, et al.
Publicado: (2012)

0589. Pravastatin exerts opposite effects on splanchnic microcirculatory oxygenation during sham or septic conditions in an animal model of polymicrobial sepsis
por: Beck, C, et al.
Publicado: (2014)

Vasopressin secretion in sepsis-surviving animals following dehydration
por: Tazinafo, Lucas Favaretto, et al.
Publicado: (2013)

Forty percent of hospitalizations after severe sepsis are potentially preventable
por: Prescott, HC, et al.
Publicado: (2014)

Impact of obesity on outcomes in patients with sepsis
por: Dobesh, PP, et al.
Publicado: (2014)

0976. Similar effect of albumin given either as a rapid bolus or slow infusion in a large animal model of sepsis
por: von Seth, M, et al.
Publicado: (2014)

Modelling immune responses in sepsis
por: Grealy, R, et al.
Publicado: (2012)

P22. Immunomodulation induced by resveratrol or genistein on proliferation and apoptosis of tumour colon cells
por: Brasoveanu, L, et al.
Publicado: (2014)

0099. Nitrite reductase activity during sepsis
por: Simon, V, et al.
Publicado: (2014)

P29 - Intestinal helminth Enterobius vermicularis as an immunomodulator factor
por: Patsantara, Giannoula, et al.
Publicado: (2014)

PA03.16. Role of herbal immunomodulators in Paediatric practice
por: Manohar, I Nilesh, et al.
Publicado: (2013)

Does clopidogrel change morbidity and mortality in ICU sepsis patients?
por: Klepser, DG, et al.
Publicado: (2014)

Expression of apolipoproteins L in neutrophils during sepsis
por: Akl, I, et al.
Publicado: (2015)

Antibacterial therapy in ovine model of sepsis
por: Nakano, Y, et al.
Publicado: (2006)

Altered plasma proteome during an early phase of an experimental model of peritonitis-induced sepsis
por: Karvunidis, T, et al.
Publicado: (2009)

Poster 2002: Transfer factor may provide immunomodulation in cutaneous tuberculosis
por: Vidal, Laura, et al.
Publicado: (2014)

The new sepsis marker, sCD14-ST, induction mechanism in the rabbit sepsis models
por: Shirakawa, K, et al.
Publicado: (2010)

Immunomodulation and infection: identification of small molecule TLR3 blockers to combat deleterious inflammation in pneumonia
por: Sônego, F, et al.
Publicado: (2014)

Estradiol cypionate modulates immunological response during sepsis
por: da Silva, Luiz E, et al.
Publicado: (2013)

Lymphocyte phenotype during severe sepsis and septic shock
por: Le Dorze, M, et al.
Publicado: (2015)

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis
por: Balak, Deepak MW, et al.
Publicado: (2011)

Natural immunomodulator preimplantation factor PIF affected cancer growth in malignant melanomas
por: Kotlan, Beatrix, et al.
Publicado: (2014)

PA02.14. A review on immunomodulator activity of Yashtimadhu (Glycyrriza Glabra).
por: Kumar, Krishan, et al.
Publicado: (2013)

Cell-culture model to study endothelial activation in sepsis
por: Eichhorn, T, et al.
Publicado: (2015)

Cytokine response in severe sepsis: predicting and modelling the course of illness
por: Malaska, J, et al.
Publicado: (2010)

Immunological modulation of estrogen during sepsis
por: Stabile, AM, et al.
Publicado: (2012)

Role of TREM-1 in endothelial dysfunction during experimental sepsis
por: Boufenzer, A, et al.
Publicado: (2012)

A sepsis progression model in humans: characterization of biomarkers descriptive of sepsis progression
por: Footer, BW, et al.
Publicado: (2011)

Cardiogenic shock: an experimental animal model
por: Tanamati, C, et al.
Publicado: (2005)

Effects of PPARγ in dendritic cells during severe sepsis and sepsis-induced immunosuppression
por: Molinaro, Raphael, et al.
Publicado: (2013)

PA02.10. A review on immunomodulator activity of some indiginious medical plants
por: Dutt, S Brahm
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hhka4947uh5lc7n6ke7ohsmctb